Stay informed with the latest updates for the inheritable blood disorders community.

Advocacy & Legislative
Your Access to Healthcare Is at Risk!
Your Access to Healthcare Is at Risk!
Advocacy & Legislative
Bleeding Disorder Organizations Oppose Graham-Cassidy-Heller-Johnson Bill
Bleeding Disorder Organizations Oppose Graham-Cassidy-Heller-Johnson Bill…
NBDF & Community
Irma Disaster Relief for Our Families
Irma Disaster Relief for Our Families
Medical
Renowned Hematologist Harold R. Roberts Dies at Age 87
Renowned Hematologist Harold R. Roberts Dies at Age 87
Medical
Study Yields Important Findings on the Functions of von Willebrand Factor
Study Yields Important Findings on the Functions of von Willebrand Factor…
Industry
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Accepts License Application and Grants Priority Review for Emicizumab…
NBDF & Community
7 Ways You Can Prepare for Emergencies
7 Ways You Can Prepare for Emergencies
Industry
Alnylam Reports Patient Death in Fitusiran Clinical Study
Alnylam Reports Patient Death in Fitusiran Clinical Study
Industry
Bayer Submits Application for Long-Acting FVIII Candidate
Bayer Submits Application for Long-Acting FVIII Candidate
Medical
Genetics of Hemophilia the Focus of New Partners Module
Genetics of Hemophilia the Focus of New Partners Module
Industry
Sangamo and Pfizer Announce First Patient Treated in Hemophilia A Gene Therapy Trial
Sangamo and Pfizer Announce First Patient Treated in Hemophilia…
Industry
FDA Approves Additional Vial Sizes for Nuwiq®
Medical
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves New Combination Therapy for all Major Hepatitis C Genotypes
Industry
Pfizer to Build Gene Therapy Facility in North Carolina
Pfizer to Build Gene Therapy Facility in North Carolina
NBDF & Community
Leading Bleeding Disorders Advocacy Organizations File Hemophilia Discrimination Complaint Against Wellmark Blue Cross and Blue Shield
Leading…